• Chemotactic Crawling of Vesicles: DNA-Mediated Multivalent A

  2026-05-08

  This study provides experimental and theoretical insight into the chemotactic motion of artificial lipid vesicles that crawl along ligand-density gradients using DNA-mediated multivalent adhesion. The findings clarify the roles of binding strength and vesicle size in controlling directed movement, offering design principles relevant to synthetic biology and biomimetic motile systems.

• Filipin III: Polyene Macrolide Antibiotic for Cholesterol De

  2026-05-08

  Filipin III, a polyene macrolide antibiotic, empowers high-resolution cholesterol detection in biological membranes. This article decodes the best-practice workflows, advanced troubleshooting, and unique assay advantages that APExBIO’s Filipin III (SKU B6034) brings to membrane biology and translational research.

• Hoechst 33258: Precision DNA Staining in Tumor pH Modulation

  2026-05-07

  Explore the advanced application of Hoechst 33258 as a bis-benzimide DNA stain for precise DNA visualization and cell cycle analysis in tumor pH modulation studies. This article reveals unique insights into assay design and workflow optimization, elevating your research beyond standard protocols.

• IR-1061: Accelerating Precision Deep Tissue Molecular Imagin

  2026-05-07

  This thought-leadership article explores the pivotal role of IR-1061, a next-generation near infrared fluorescent dye, in elevating deep tissue imaging for translational biomedical research. By integrating mechanistic insights from the latest nanocatalytic therapy advances and practical guidance on workflow optimization, the article offers a strategic roadmap for researchers seeking to harness the full translational potential of IR-1061. Distinct from standard product guides, it critically examines cross-disciplinary evidence, protocol design, and competitive positioning, with a focus on long-term impact and responsible innovation.

• CUDC-907: Practical Guidance for Dual PI3K and HDAC Inhibiti

  2026-05-06

  CUDC-907 is a dual PI3K and HDAC inhibitor designed for precise in vitro modulation of cancer cell signaling, cell cycle, and apoptosis pathways. This compound addresses the need for simultaneous pathway inhibition in cell-based assays but is not validated for diagnostic or clinical applications.

• Vidarabine Monohydrate: Structural Insights and Research Fro

  2026-05-06

  Explore the unique structural and mechanistic characteristics of Vidarabine monohydrate, a pivotal antiviral research compound. This in-depth analysis clarifies its molecular action and solubility, offering advanced perspectives beyond standard protocols.

• Filipin III: Precision Cholesterol Detection in Membrane Res

  2026-05-05

  Filipin III, a leading polyene macrolide antibiotic from APExBIO, empowers researchers with unparalleled specificity in cholesterol detection within biological membranes. This article delivers actionable workflows, troubleshooting insights, and leverages novel findings on cholesterol homeostasis in metabolic disease models for optimized assay design.

• Biotin-tyramide: Technical Guidelines for TSA Signal Amplifi

  2026-05-05

  Biotin-tyramide (SKU A8011) is a specialized biotin phenol reagent engineered for robust, enzyme-mediated signal amplification in immunohistochemistry (IHC) and in situ hybridization (ISH) workflows. It offers precise biotin deposition via HRP catalysis, supporting both chromogenic and fluorescence detection. Researchers should avoid using this reagent for applications outside fixed-cell or tissue protocols, and ensure compatibility with DMSO or ethanol-based solubilization.

• Prednisone in Bench Research: Applied Workflows & Troublesho

  2026-05-04

  Prednisone, a synthetic corticosteroid, offers robust immunosuppressive and apoptotic control in translational research. This article distills actionable experimental protocols, troubleshooting strategies, and advanced workflow tips, leveraging both cutting-edge metabolomics and established immunology paradigms for reproducibility and maximum scientific impact.

• Bufalin Targets STK33 to Inhibit Triple-Negative Breast Canc

  2026-05-04

  This study identifies serine/threonine kinase 33 (STK33) as a direct molecular target of Bufalin in triple-negative breast cancer (TNBC). By elucidating Bufalin's mechanism of degrading STK33 and inhibiting TNBC cell proliferation, the research offers a promising therapeutic direction for aggressive breast cancer subtypes.

• DiscoveryProbe™ FDA-approved Drug Library in Neurotherapeuti

  2026-05-03

  Explore how the DiscoveryProbe FDA-approved Drug Library enables neurodegenerative disease drug discovery and target identification, featuring real-world assay strategies and unique evidence from recent luminescence-based screening advances.

• AO/PI Staining Solution: Precision Live/Dead Cell Discrimina

  2026-05-02

  AO/PI Staining Solution is a robust fluorescent DNA dye reagent for live/dead cell discrimination using cell membrane integrity. The dual-dye mechanism enables accurate and reproducible fluorescence-based cell viability assays, outperforming traditional methods. APExBIO's AO/PI Staining Solution (K2269) is validated for exclusion of cell debris and red blood cell interference.

• BRD4770: G9a Histone Methyltransferase Inhibitor in Cancer R

  2026-05-01

  BRD4770 stands apart as a robust G9a histone methyltransferase inhibitor, enabling direct interrogation of H3K9 methylation dynamics and cellular senescence in cancer models. This article provides actionable workflows, troubleshooting strategies, and advanced applications for maximizing the impact of BRD4770 in epigenetic regulation studies.

• Phillygenin Attenuates Diabetic Nephropathy via TLR4 and PI3

  2026-05-01

  This study demonstrates that phillygenin, a Forsythia suspensa-derived compound, mitigates diabetic nephropathy by suppressing inflammation and apoptosis through modulation of TLR4/MyD88/NF-κB and PI3K/AKT/GSK3β signaling. The findings suggest phillygenin as a promising therapeutic candidate, highlighting potential mechanistic targets for disease intervention.

• Cy5 TSA Fluorescence System Kit: Amplifying Low-Abundance De

  2026-04-30

  The Cy5 TSA Fluorescence System Kit revolutionizes immunohistochemistry and in situ hybridization by enabling 100-fold signal amplification and sensitive detection of elusive molecular targets. With rapid, HRP-catalyzed tyramide deposition, the kit streamlines workflows and addresses the challenges of low-abundance protein and nucleic acid visualization.

15866 records 1/1058 page Next 12345 下5页 Last page